A Complete Response After Pseudo-progression: Pembrolizumab for Metastatic Squamous Cell Carcinoma (SCC) of the Bladder

被引：5
作者：
Kao, Chester [1 ]
McNamara, Megan [1 ,2 ,3 ]
Alley, Chris [4 ]
Spector, Neil [1 ,2 ,3 ]
Jauhari, Shekeab [1 ]
Gupta, Rajan T. [5 ]
Zhang, Tian [1 ,2 ]
Zhu, Jason [1 ]
机构：
[1] Duke Univ, Dept Med, Durham, NC USA
[2] Duke Univ, Duke Canc Inst, Durham, NC USA
[3] Durham VA Med Ctr, Dept Hematol & Oncol, Durham, NC USA
[4] Duke Univ, Dept Pathol, Durham, NC 27706 USA
[5] Duke Univ, Dept Radiol, Durham, NC 27710 USA
来源：
CLINICAL GENITOURINARY CANCER | 2019年 / 17卷 / 03期
关键词：
Bladder cancer; Cisplatin ineligible; Immune checkpoint inhibitors; Metastatic bladder squamous cell carcinoma; PD-1; inhibitor; Psuedoprogression; IMMUNE-RELATED RESPONSE; RADICAL CYSTECTOMY; CISPLATIN; SURVIVAL; THERAPY; PSEUDOPROGRESSION; METHOTREXATE; VINBLASTINE; DOXORUBICIN; OUTCOMES;
D O I：
10.1016/j.clgc.2019.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E672 / E677
页数：6
相关论文
共 50 条
[21]   Complete response in metastatic renal cell carcinoma after radiotherapy and everolimus: a clinical case and review of the literature [J].
Detti, Beatrice ;
Francolini, Giulio ;
Becherini, Carlotta ;
Olmetto, Emanuela ;
Giacomelli, Irene ;
Scartoni, Daniele ;
Greto, Daniela ;
Baldazzi, Valentina ;
Simontacchi, Gabriele ;
Meattini, Icro ;
Livi, Lorenzo .
JOURNAL OF CHEMOTHERAPY, 2016, 28 (05) :432-434
[22]   Long-Term Survival With Pembrolizumab Re-administration After Pseudo-Progression With Immune-Related Interstitial Lung Disease in a Patient With Non-small Cell Lung Cancer [J].
Nakashima, Koki ;
Demura, Yoshiki ;
Akai, Masaya ;
Ishizuka, Tamotsu .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
[23]   Pathological Complete Response to a Single Dose of Pembrolizumab-Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report [J].
Matsumura, Yugo ;
Ichihara, Seiya ;
Nii, Kaori ;
Nanjo, Kazumasa ;
Kadota, Naoki ;
Okano, Yoshio ;
Machida, Hisanori ;
Hatakeyama, Nobuo ;
Hino, Hiroyuki ;
Naruse, Keishi ;
Shinohara, Tsutomu ;
Sakiyama, Shoji ;
Takeuchi, Eiji .
THORACIC CANCER, 2025, 16 (02)
[24]   Case Report: Two Cases of Chemotherapy Refractory Metastatic Penile Squamous Cell Carcinoma With Extreme Durable Response to Pembrolizumab [J].
Chahoud, Jad ;
Skelton, William Paul ;
Spiess, Philippe E. ;
Walko, Christine ;
Dhillon, Jasreman ;
Gage, Kenneth L. ;
Johnstone, Peter A. S. ;
Jain, Rohit K. .
FRONTIERS IN ONCOLOGY, 2020, 10
[25]   Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature [J].
Deinlein, Teresa ;
Lax, Sigurd F. ;
Schwarz, Thomas ;
Giuffrida, Roberta ;
Schmid-Zalaudek, Karin ;
Zalaudek, Iris .
EUROPEAN JOURNAL OF CANCER, 2017, 83 :99-102
[26]   Risk Factors for Recurrence in Esophageal Squamous Cell Carcinoma Without Pathological Complete Response After Trimodal Therapy [J].
Kurokawa, Tomoaki ;
Hamai, Yoichi ;
Emi, Manabu ;
Ibuki, Yuta ;
Yoshikawa, Toru ;
Ohsawa, Manato ;
Hirohata, Ryosuke ;
Okada, Morihito .
ANTICANCER RESEARCH, 2020, 40 (08) :4387-4394
[27]   Development of a nomogram for the prediction of pathological complete response after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma [J].
Chao, Yin-Kai ;
Chang, Hsien-Kun ;
Tseng, Chen-Kan ;
Liu, Yun-Hen ;
Wen, Yu-Wen .
DISEASES OF THE ESOPHAGUS, 2017, 30 (02)
[28]   Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma [J].
Huang, Ren-Wen ;
Chao, Yin-Kai ;
Wen, Yu-Wen ;
Chang, Hsien-Kun ;
Tseng, Chen-Kan ;
Chan, Sheng-Chieh ;
Liu, Yun-Hen .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2014, 12
[29]   Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy [J].
Aaron Dotson ;
Allison May ;
Facundo Davaro ;
Syed Johar Raza ;
Sameer Siddiqui ;
Zachary Hamilton .
International Journal of Clinical Oncology, 2019, 24 :706-711
[30]   Vitiligo Adverse Event Observed in a Patient With Durable Complete Response After Nivolumab for Metastatic Renal Cell Carcinoma [J].
Billon, Emilien ;
Walz, Jochen ;
Brunelle, Serge ;
Thomassin, Jeanne ;
Salem, Naji ;
Guerin, Mathilde ;
Vicier, Cecile ;
Dermeche, Slimane ;
Albiges, Laurence ;
Tantot, Florence ;
Nenan, Soazig ;
Pignot, Geraldine ;
Gravis, Gwenaelle .
FRONTIERS IN ONCOLOGY, 2019, 9
12345